{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:46:32Z","timestamp":1785764792390,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Gastrointestinal stromal tumors (GISTs) are molecularly heterogeneous neoplasms whose management depends on individualized, multidisciplinary decision-making. While multidisciplinary tumor boards (MTBs) represent the standard of care, access remains limited in many clinical settings. This study evaluates the performance of two large language models in generating GIST MTB recommendations and assesses their agreement with expert MTB decisions using predefined clinical evaluation criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective single-center study included 99 GIST cases discussed at an institutional MTB. A structured prompt was developed to extract clinical variables and generate treatment recommendations. ChatGPT-5 and Qwen3 were independently evaluated across five predefined domains: diagnostic recommendations, therapeutic modalities, treatment sequence and timing, systemic therapy regimen selection, and clinical contextualization. Two expert reviewers scored all outputs in a blinded fashion. Normalized scores, inter-model comparisons, perfect-case rates, and inter-rater agreement were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both models demonstrated high concordance with expert MTB recommendations, with mean total normalized scores of 0.901 for ChatGPT-5 and 0.875 for Qwen3, without a significant difference between models (\n                      <jats:italic>p\u2009&gt;<\/jats:italic>\n                      \u20090.05). Perfect agreement was observed in 52.5% of ChatGPT-5 cases and 48.5% of Qwen3 cases (\n                      <jats:italic>p\u2009&gt;<\/jats:italic>\n                      \u20090.05). Diagnostic recommendations scored significantly lower than all other domains in both models (all adjusted\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u20090.05). Overall inter-rater agreement was almost perfect (weighted Cohen\u2019s kappa=0.978).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Both models demonstrated high agreement with expert GIST MTB recommendations, with no significant performance difference between them. Diagnostic reasoning represented the weakest domain, reflecting the challenge of reconstructing context-dependent workup decisions from tumor board documentation. These findings support a potential assistive role for LLMs in GIST MTB workflows, while underscoring the continued necessity of expert oversight.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16537-7","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:44:58Z","timestamp":1785559498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision oncology meets Generative AI: assessing large language models in multidisciplinary GIST tumor boards"],"prefix":"10.1186","volume":"26","author":[{"given":"Reza","family":"Dehdab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Mankertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ghibes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour","family":"Maalouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Stroh\u00e4ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Benzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Zender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Afat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1961-9382","authenticated-orcid":false,"given":"Christoph K. W.","family":"Deinzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"16537_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/17588359231192388","volume":"2023","author":"C Serrano","year":"2023","unstructured":"Serrano C, Mart\u00edn-Broto J, Asencio-Pascual JM, L\u00f3pez-Guerrero JA, Rubi\u00f3-Casadevall J, Bagu\u00e9 S, et al. GEIS Guidelines for gastrointestinal stromal tumors. Ther Adv Med Oncol. 2023;2023:15. https:\/\/doi.org\/10.1177\/17588359231192388.","journal-title":"Ther Adv Med Oncol"},{"key":"16537_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S004280000338\/METRICS","volume":"438","author":"M Miettinen","year":"2001","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors - Definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch. 2001;438:1\u201312. https:\/\/doi.org\/10.1007\/S004280000338\/METRICS.","journal-title":"Virchows Arch"},{"key":"16537_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1200\/JCO.2017.74.9705","volume":"36","author":"M Mehren","year":"2018","unstructured":"Mehren M, Joensuu H. Gastrointestinal stromal tumors. J Clin Oncol. 2018;36:136\u201343. https:\/\/doi.org\/10.1200\/JCO.2017.74.9705.","journal-title":"J Clin Oncol"},{"key":"16537_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/S12029-014-9615-X","volume":"45","author":"RL Jones","year":"2014","unstructured":"Jones RL. Practical aspects of risk assessment in gastrointestinal stromal tumors. J Gastrointest Cancer. 2014;45:262. https:\/\/doi.org\/10.1007\/S12029-014-9615-X.","journal-title":"J Gastrointest Cancer"},{"key":"16537_CR5","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3748\/WJG.V24.I18.1925","volume":"24","author":"JM Sanchez-Hidalgo","year":"2018","unstructured":"Sanchez-Hidalgo JM, Duran-Martinez M, Molero-Payan R, Rufian-Pe\u00f1a S, Arjona-Sanchez A, Casado-Adam A, et al. Gastrointestinal stromal tumors: a multidisciplinary challenge. World J Gastroenterol. 2018;24:1925. https:\/\/doi.org\/10.3748\/WJG.V24.I18.1925.","journal-title":"World J Gastroenterol"},{"key":"16537_CR6","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1007\/S12094-023-03177-7","volume":"25","author":"C Serrano","year":"2023","unstructured":"Serrano C, \u00c1lvarez R, Carrasco JA, Marquina G, Mart\u00ednez-Garc\u00eda J, Mart\u00ednez-Mar\u00edn V, et al. SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022). Clin Transl Oncol. 2023;25:2707\u201317. https:\/\/doi.org\/10.1007\/S12094-023-03177-7.","journal-title":"Clin Transl Oncol"},{"key":"16537_CR7","doi-asserted-by":"publisher","first-page":"1592004","DOI":"10.3389\/FONC.2025.1592004\/TEXT","volume":"15","author":"B Calukovic","year":"2025","unstructured":"Calukovic B, Benzler K, Carter ME, Daigeler A, Thiel JT, Jakob J, et al. An analysis of the distribution of bone and soft tissue sarcoma diagnoses and their disparities in Southwest Germany: a multicenter approach. Front Oncol. 2025;15:1592004. https:\/\/doi.org\/10.3389\/FONC.2025.1592004\/TEXT.","journal-title":"Front Oncol"},{"key":"16537_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.annonc.2021.09.005","volume":"33","author":"PG Casali","year":"2022","unstructured":"Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, et al. Gastrointestinal stromal tumours: ESMO\u2013EURACAN\u2013GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up \u2606. Ann Oncol. 2022;33:20\u201333. https:\/\/doi.org\/10.1016\/j.annonc.2021.09.005.","journal-title":"Ann Oncol"},{"key":"16537_CR9","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/J.ANNONC.2021.07.006","volume":"32","author":"A Gronchi","year":"2021","unstructured":"Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS clinical practice guidelines for diagnosis, treatment and follow-up\u2606. Ann Oncol. 2021;32:1348\u201365. https:\/\/doi.org\/10.1016\/J.ANNONC.2021.07.006.","journal-title":"Ann Oncol"},{"key":"16537_CR10","doi-asserted-by":"publisher","first-page":"e079559","DOI":"10.1136\/BMJOPEN-2023-079559","volume":"14","author":"NLW Law","year":"2024","unstructured":"Law NLW, Hong LW, Tan SSN, Foo CJ, Lee D, Voon PJ. Barriers and challenges of multidisciplinary teams in oncology management: a scoping review protocol. BMJ Open. 2024;14:e079559. https:\/\/doi.org\/10.1136\/BMJOPEN-2023-079559.","journal-title":"BMJ Open"},{"key":"16537_CR11","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1136\/BMJOQ-2022-002130","volume":"12","author":"JEW Walraven","year":"2023","unstructured":"Walraven JEW, Verhoeven RHA, Van Der MR, Der HJJMV, Lemmens VEPP, Hesselink G, et al. Facilitators and barriers to conducting an efficient, competent and high-quality oncological multidisciplinary team meeting. BMJ Open Qual. 2023;12:2130. https:\/\/doi.org\/10.1136\/BMJOQ-2022-002130.","journal-title":"BMJ Open Qual"},{"key":"16537_CR12","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/JJCO\/HYAA051","volume":"50","author":"X Zhao","year":"2020","unstructured":"Zhao X, Zhang Y, Ma X, Chen Y, Xi J, Yin X, et al. Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China. Jpn J Clin Oncol. 2020;50:852\u20138. https:\/\/doi.org\/10.1093\/JJCO\/HYAA051.","journal-title":"Jpn J Clin Oncol"},{"key":"16537_CR13","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1016\/j.acra.2025.07.041","volume":"32","author":"R Dehdab","year":"2025","unstructured":"Dehdab R, Mankertz F, Brendel JM, Maalouf N, Kaya K, Afat S, et al. LLM-Based Extraction of Imaging Features from Radiology Reports: Automating Disease Activity Scoring in Crohn\u2019s Disease. Acad Radiol. 2025;32:5869\u201377. https:\/\/doi.org\/10.1016\/j.acra.2025.07.041.","journal-title":"Acad Radiol"},{"key":"16537_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.IMED.2025.01.001;PAGE:STRING:ARTICLE\/CHAPTER","volume":"5","author":"J Li","year":"2025","unstructured":"Li J, Zhou Z, Lyu H, Wang Z. Large language models-powered clinical decision support: enhancing or replacing human expertise? Intelligent Medicine. 2025;5:1\u20134. https:\/\/doi.org\/10.1016\/J.IMED.2025.01.001;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"Intelligent Medicine"},{"key":"16537_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/S00432-026-06432-W","volume":"152","author":"R Dehdab","year":"2026","unstructured":"Dehdab R, Afat S, Mankertz F, Brendel JM, Maalouf N, Werner S, et al. When AI joins the table: evaluating large language model performance in soft tissue sarcoma tumor board decisions. J Cancer Res Clin Oncol. 2026;152:52. https:\/\/doi.org\/10.1007\/S00432-026-06432-W.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16537_CR16","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1007\/S12094-025-03905-1","volume":"27","author":"EC Erdat","year":"2025","unstructured":"Erdat EC, Yal\u00e7\u0131ner M, \u00d6r\u00fcnc\u00fc MB, \u00dcr\u00fcn Y, \u015eenler F\u00c7. Assessing the accuracy of the GPT-4 model in multidisciplinary tumor board decision prediction. Clin Transl Oncol. 2025;27:3793\u2013802. https:\/\/doi.org\/10.1007\/S12094-025-03905-1.","journal-title":"Clin Transl Oncol"},{"key":"16537_CR17","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1007\/S00405-024-08828-1","volume":"281","author":"B Schmidl","year":"2024","unstructured":"Schmidl B, H\u00fctten T, Pigorsch S, St\u00f6gbauer F, Hoch CC, Hussain T, et al. Assessing the use of the novel tool Claude 3 in comparison to ChatGPT 4.0 as an artificial intelligence tool in the diagnosis and therapy of primary head and neck cancer cases. Eur Arch Otorhinolaryngol. 2024;281:6099\u2013109. https:\/\/doi.org\/10.1007\/S00405-024-08828-1.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"16537_CR18","doi-asserted-by":"publisher","unstructured":"Sorin V, Klang E, Sklair-Levy M, Cohen I, Zippel DB, Balint Lahat N, et al. Large language model (ChatGPT) as a support tool for breast tumor board. NPJ Breast Cancer. 2023;9. https:\/\/doi.org\/10.1038\/S41523-023-00557-8.","DOI":"10.1038\/S41523-023-00557-8"},{"key":"16537_CR19","unstructured":"Lauer U. Figure 1. Created in BioRender. 2026. https:\/\/BioRender.com\/mjeawim."},{"key":"16537_CR20","unstructured":"Introducing GPT-5 | OpenAI. https:\/\/openai.com\/index\/introducing-gpt-5\/. Accessed 3 July 2026."},{"key":"16537_CR21","unstructured":"Qwen. https:\/\/qwen.ai\/blog?id=qwen3. Accessed 3 July 2026."},{"key":"16537_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/BJU.15495;PAGE:STRING:ARTICLE\/CHAPTER","volume":"128","author":"DA Winters","year":"2021","unstructured":"Winters DA, Soukup T, Sevdalis N, Green JSA, Lamb BW. The cancer multidisciplinary team meeting: in need of change? History, challenges and future perspectives. BJU Int. 2021;128:271\u20139. https:\/\/doi.org\/10.1111\/BJU.15495;PAGE:STRING:ARTICLE\/CHAPTER.","journal-title":"BJU Int"},{"key":"16537_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-023-00557-8","volume":"9","author":"V Sorin","year":"2023","unstructured":"Sorin V, Klang E, Sklair-Levy M, Cohen I, Zippel DB, Balint Lahat N, et al. Large language model (ChatGPT) as a support tool for breast tumor board. NPJ Breast Cancer. 2023;9:1\u20134. https:\/\/doi.org\/10.1038\/s41523-023-00557-8.","journal-title":"NPJ Breast Cancer."},{"key":"16537_CR24","doi-asserted-by":"publisher","unstructured":"Hack S, Karni RJ, Maniaci A, Fundakowski CE, Castellani L, Incandela F, et al. Evaluation of large language models as decision support tools for head and neck cancer management: A blinded multidisciplinary simulation study. Oral Oncol. 2026;174. https:\/\/doi.org\/10.1016\/J.ORALONCOLOGY.2026.107877.","DOI":"10.1016\/J.ORALONCOLOGY.2026.107877"},{"key":"16537_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1080\/1750743X.2025.2580272","volume":"17","author":"R Ismayilov","year":"2025","unstructured":"Ismayilov R, Altundag O, Akcali Z. Simulating a virtual tumor board with large language models: a pilot study in NSCLC patients receiving immunotherapy. Immunotherapy. 2025;17:1105\u201313. https:\/\/doi.org\/10.1080\/1750743X.2025.2580272.","journal-title":"Immunotherapy"},{"key":"16537_CR26","doi-asserted-by":"publisher","unstructured":"Harbr\u00fccker M, Menge F, Taebi A, N\u00f6renberg D, Speer T, Rei\u00dffelder C, et al. Evaluating reasoning models for therapy recommendations in gastrointestinal stromal tumors: expert and LLM-based evaluations of OpenAI o1 and DeepSeek-R1. J Cancer Res Clin Oncol. 2026. https:\/\/doi.org\/10.1007\/S00432-026-06489-7.","DOI":"10.1007\/S00432-026-06489-7"},{"key":"16537_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/S10120-015-0526-8","volume":"19","author":"T Nishida","year":"2015","unstructured":"Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 2015;19:3. https:\/\/doi.org\/10.1007\/S10120-015-0526-8.","journal-title":"Gastric Cancer"},{"key":"16537_CR28","doi-asserted-by":"publisher","first-page":"564852","DOI":"10.3389\/FONC.2020.564852","volume":"10","author":"XH Du","year":"2020","unstructured":"Du XH, Wei H, Zhang P, Yao WT, Cai QQ. Heterogeneity of Soft Tissue Sarcomas and Its Implications in Targeted Therapy. Front Oncol. 2020;10:564852. https:\/\/doi.org\/10.3389\/FONC.2020.564852.","journal-title":"Front Oncol"},{"key":"16537_CR29","doi-asserted-by":"publisher","first-page":"114082","DOI":"10.1016\/J.ISCI.2025.114082","volume":"28","author":"X Wang","year":"2025","unstructured":"Wang X, Wang Q, Ding G, Wang J, Tang Y, Feng Y. Artificial intelligence in multidisciplinary tumor boards enhancing decision making and clinical outcomes in oncology. iScience. 2025;28:114082. https:\/\/doi.org\/10.1016\/J.ISCI.2025.114082.","journal-title":"iScience"},{"key":"16537_CR30","doi-asserted-by":"publisher","unstructured":"Komenda A, Makowski M, Can E, Prucker P, Busch F, Wachter A, et al. Development and Evaluation of a Retrieval-Augmented Generation System for Radiology Guidelines. J Imaging Inform Med. 2026. https:\/\/doi.org\/10.1007\/S10278-025-01835-6.","DOI":"10.1007\/S10278-025-01835-6"},{"key":"16537_CR31","doi-asserted-by":"publisher","unstructured":"Aghamaliyev U, Karimbayli J, Giessen-Jung C, Matthias I, Unger K, Andrade D, et al. ChatGPT\u2019s Gastrointestinal Tumor Board Tango: A limping dance partner? Eur J Cancer. 2024;205. https:\/\/doi.org\/10.1016\/j.ejca.2024.114100.","DOI":"10.1016\/j.ejca.2024.114100"},{"key":"16537_CR32","doi-asserted-by":"publisher","unstructured":"Rinderknecht E, Haas M, Schnabel MJ, Kravchuk AP, Sch\u00e4fer C, Siepmann S, et al. Benchmarking Large Language Models Against Multidisciplinary Tumor Boards in Urological Oncology: Results from the Blinded, Prospective CONCORDIA Study. Eur Urol Oncol. 2025;0. https:\/\/doi.org\/10.1016\/j.euo.2025.11.016.","DOI":"10.1016\/j.euo.2025.11.016"},{"key":"16537_CR33","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.3390\/CURRONCOL31090369","volume":"31","author":"V Nardone","year":"2024","unstructured":"Nardone V, Marmorino F, Germani MM, Cichowska-Cwali\u0144ska N, Menditti VS, Gallo P, et al. The Role of Artificial Intelligence on Tumor Boards: Perspectives from Surgeons, Medical Oncologists and Radiation Oncologists. Curr Oncol. 2024;31:4984\u20135007. https:\/\/doi.org\/10.3390\/CURRONCOL31090369.","journal-title":"Curr Oncol."},{"key":"16537_CR34","doi-asserted-by":"publisher","unstructured":"Hao Y, Qiu Z, Holmes J, L\u00f6ckenhoff CE, Liu W, Ghassemi M, et al. Large language model integrations in cancer decision-making: a systematic review and meta-analysis. NPJ Digit Med. 2025;8. https:\/\/doi.org\/10.1038\/S41746-025-01824-7.","DOI":"10.1038\/S41746-025-01824-7"},{"key":"16537_CR35","doi-asserted-by":"publisher","first-page":"1757059","DOI":"10.3389\/OR.2026.1757059","volume":"20","author":"B Konzmann","year":"2026","unstructured":"Konzmann B, Henkel M, Breit C, Wetterauer C. Applications of large language models in tumor boards: a systematic review. Oncol Rev. 2026;20:1757059. https:\/\/doi.org\/10.3389\/OR.2026.1757059.","journal-title":"Oncol Rev"},{"key":"16537_CR36","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/S11606-024-08657-2","volume":"39","author":"D Khullar","year":"2024","unstructured":"Khullar D, Wang X, Wang F. Large language models in health care: charting a path toward accurate, explainable, and secure AI. J Gen Intern Med. 2024;39:1239. https:\/\/doi.org\/10.1007\/S11606-024-08657-2.","journal-title":"J Gen Intern Med"},{"key":"16537_CR37","doi-asserted-by":"publisher","first-page":"e58329","DOI":"10.2196\/58329","volume":"26","author":"J Seo","year":"2024","unstructured":"Seo J, Choi D, Kim T, Cha WC, Kim M, Yoo H, et al. Evaluation framework of large language models in medical documentation: development and usability study. J Med Internet Res. 2024;26:e58329. https:\/\/doi.org\/10.2196\/58329.","journal-title":"J Med Internet Res"},{"key":"16537_CR38","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.3390\/CANCERS15245892\/S1","volume":"15","author":"L T\u00f6gel","year":"2023","unstructured":"T\u00f6gel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, et al. Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center. Cancers (Basel). 2023;15:5892. https:\/\/doi.org\/10.3390\/CANCERS15245892\/S1.","journal-title":"Cancers (Basel)"},{"key":"16537_CR39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1093\/ONCOLO\/OYAE077","volume":"29","author":"M Angel","year":"2024","unstructured":"Angel M, Demiray M, Di\u015fel U, Passos J. The value of virtual molecular tumor boards for informed clinical decision-making. Oncologist. 2024;29:554. https:\/\/doi.org\/10.1093\/ONCOLO\/OYAE077.","journal-title":"Oncologist"},{"key":"16537_CR40","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/S12254-024-00977-7","volume":"17","author":"L Boos","year":"2024","unstructured":"Boos L, Wicki A. The molecular tumor board\u2014a key element of precision oncology. Memo Mag Eur Med Oncol. 2024;17:190\u20133. https:\/\/doi.org\/10.1007\/S12254-024-00977-7.","journal-title":"Memo Mag Eur Med Oncol"},{"key":"16537_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41746-024-01079-8","volume":"7","author":"J Huang","year":"2024","unstructured":"Huang J, Yang DM, Rong R, Nezafati K, Treager C, Chi Z, et al. A critical assessment of using ChatGPT for extracting structured data from clinical notes. NPJ Dig Med. 2024;7:106. https:\/\/doi.org\/10.1038\/s41746-024-01079-8.","journal-title":"NPJ Dig Med."},{"key":"16537_CR42","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.annonc.2025.09.001","volume":"36","author":"EYT Wong","year":"2025","unstructured":"Wong EYT, Verlingue L, Aldea M, Franzoi MA, Umeton R, Halabi S, et al. ESMO guidance on the use of Large Language Models in Clinical Practice (ELCAP). Ann Oncol. 2025;36:1447\u201357. https:\/\/doi.org\/10.1016\/j.annonc.2025.09.001.","journal-title":"Ann Oncol"},{"key":"16537_CR43","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.3390\/JCM15062208","volume":"15","author":"S Malerba","year":"2026","unstructured":"Malerba S, Vladimirov M, Goyal A, Dulskas A, Bau\u0161ys A, Cwalinski T, et al. Artificial Intelligence Applications in Gastric Cancer Surgery: Bridging Early Diagnosis and Responsible Precision Medicine. J Clin Med. 2026;15:2208. https:\/\/doi.org\/10.3390\/JCM15062208.","journal-title":"J Clin Med."},{"key":"16537_CR44","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2147\/IJGM.S456659","volume":"17","author":"Y Mu","year":"2024","unstructured":"Mu Y, He D. The Potential Applications and Challenges of ChatGPT in the Medical Field. Int J Gen Med. 2024;17:817. https:\/\/doi.org\/10.2147\/IJGM.S456659.","journal-title":"Int J Gen Med."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16537-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16537-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16537-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T12:59:32Z","timestamp":1785761972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16537-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16537"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16537-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"13 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was conducted at the University Hospital T\u00fcbingen and the Comprehensive Cancer Center T\u00fcbingen-Stuttgart, T\u00fcbingen. Approval for the study was obtained from the Institutional Review Board of the University of T\u00fcbingen (Ethics Committee of the Faculty of Medicine of the University of T\u00fcbingen, reference no. 418\/2024BO2). Clinical trial number: not applicable. Due to the retrospective nature of the analysis and the use of fully anonymized patient data, the requirement for informed consent was waived. All procedures were performed in accordance with the ethical standards of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"CKWD is a consulting or advisory board member for Boehringer Ingelheim Pharma. He has received lecture honoraria from PharmaMar. In addition, he has accepted imbursement for travel, accommodation or congress registration expenses from Boehringer Ingelheim Pharma, Deciphera Pharmaceuticals, Lilly, Sanofi and Pierre Fabre Pharma (all outside the submitted work).KB has accepted imbursement for travel, accommodation or congress registration expenses from Boehringer Ingelheim Pharma, Pierre Fabre Pharma and Lilly Pharma (all outside the submitted work).Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"930"}}